Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Vigil Neuroscience, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- −2 vs. Q2 2023
- Shares held
- 25.5M
- −207.5K (−0.8%) vs. Q2 2023
- Total value
- $137.7M
- −$104.4M (−43.1%) vs. Q2 2023
- New holders
- 2
- 14 more added
- Sold out
- 4
- 12 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $31.5M | 4.87% | 00.0% | Unchanged |
| Northpond Ventures, LLC | 4,214,498 | $22.7M | 65.40% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,166,113 | $11.7M | 0.01% | −14,211−0.7% | Reduced |
| Artal Group S.A. | 1,908,135 | $10.3M | 0.45% | −3,056−0.2% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 1,827,400 | $9.85M | 0.22% | −224,610−10.9% | Reduced |
| BVF Inc | 1,813,633 | $9.78M | 0.26% | 00.0% | Unchanged |
| Deep Track Capital, LP | 1,767,131 | $9.52M | 0.37% | −6,278−0.4% | Reduced |
| BlackRock Inc. | 847,279 | $4.57M | 0.00% | +25,827+3.1% | Added |
| Vanguard Group Inc | 793,966 | $4.28M | 0.00% | +1,730+0.2% | Added |
| Cormorant Asset Management, LP | 616,786 | $3.32M | 0.19% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $3.02M | 1.21% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $2.54M | 0.07% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 448,891 | $2.42M | 0.06% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 305,175 | $1.65M | 0.00% | +20,332+7.1% | Added |
| Harvard Management Co Inc | 289,460 | $1.56M | 0.18% | 00.0% | Unchanged |
| State Street Corp | 277,613 | $1.50M | 0.00% | +17,914+6.9% | Added |
| Trustees of Columbia University in the City of New York | 192,973 | $1.04M | 1.91% | 00.0% | Unchanged |
| Logos Global Management LP | 188,390 | $1.02M | 0.14% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 172,308 | $928.7K | 0.29% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 146,202 | $788.0K | 0.00% | +133,194+1,023.9% | Added |
| FMR LLC | 141,082 | $760.4K | 0.00% | +682+0.5% | Added |
| Northern Trust Corp | 125,734 | $677.7K | 0.00% | +1,372+1.1% | Added |
| Barclays PLC | 104,590 | $563.7K | 0.00% | −312−0.3% | Reduced |
| Citigroup Inc | 64,303 | $346.6K | 0.00% | −4,774−6.9% | Reduced |
| Bank of New York Mellon Corp | 48,488 | $261.4K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 41,968 | $226.2K | 0.00% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 24,715 | $133.2K | 0.00% | 00.0% | Unchanged |
| PEAK6 Investments LLC | 23,796 | $128.3K | 0.01% | +9,459+66.0% | Added |
| Bank of America Corp | 23,601 | $127.2K | 0.00% | +3,468+17.2% | Added |
| Rhumbline Advisers | 18,048 | $97.3K | 0.00% | +1,690+10.3% | Added |
| Morgan Stanley | 12,359 | $66.6K | 0.00% | −3,266−20.9% | Reduced |
| Ensign Peak Advisors, Inc | 11,924 | $64.3K | 0.00% | +11,924 | New |
| Laurion Capital Management LP | 10,839 | $58.4K | 0.00% | −88,850−89.1% | Reduced |
| JPMorgan Chase & Co | 10,415 | $56.1K | 0.00% | −2,390−18.7% | Reduced |
| New York State Common Retirement Fund | 10,165 | $54.8K | 0.00% | +165+1.7% | Added |
| American International Group, Inc. | 8,019 | $43.2K | 0.00% | +285+3.7% | Added |
| Wells Fargo & Company | 3,952 | $21.3K | 0.00% | −2,144−35.2% | Reduced |
| Royal Bank of Canada | 3,819 | $21.0K | 0.00% | +320+9.1% | Added |
| California State Teachers Retirement System | 3,546 | $19.1K | 0.00% | −1,799−33.7% | Reduced |
| Tower Research Capital LLC (TRC) | 2,351 | $12.7K | 0.00% | +1,726+276.2% | Added |
| Legal & General Group Plc | 1,554 | $8.51K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,563 | $8.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,327 | $7.15K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 30 | $162 | 0.00% | +30 | New |
| Coppell Advisory Solutions LLC | 34 | – | – | −2,450−98.6% | Reduced |
| Bank of Montreal | 0 | $0 | 0.00% | −73,243−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −9,105−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −944−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −143−100.0% | Sold out |